Y K Shi

Suggest Changes
Learn More
7522 Background: Icotinib is a potent and selective EGFR-TKI. Of 88 kinases profiled, Icotinib (Ic) powerfully inhibited EGFR and its 3 mutants, with no meaningful inhibition of the rest of kinases(More)